Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438137 · ClinicalTrials.gov registry record · Phase 2
Dimethyl Fumarate for Obstructive Sleep Apnea
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT02438137 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 65 participants.
The verdict
NCT02438137, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
The overall purpose of this study is to determine whether the oral medication dimethyl fumarate is an effective treatment for obstructive sleep apnea in patients who are unable, unwilling, or uneager to use positive airway pressure therapy.
Interventions
- DRUG Placebo
- DRUG Dimethyl fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438137
The ClinicalTrials.gov registry entry for NCT02438137 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02438137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438137 about?
NCT02438137 is a clinical study titled "Dimethyl Fumarate for Obstructive Sleep Apnea". The overall purpose of this study is to determine whether the oral medication dimethyl fumarate is an effective treatment for obstructive sleep apnea in patients who are unable, unwilling, or uneager to use positive airway pressure therapy.
What is the current status of trial NCT02438137?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2015-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02438137?
The interventions under investigation include: Placebo (DRUG), Dimethyl fumarate (DRUG).
Who is sponsoring clinical trial NCT02438137?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.